IDDO and the Drugs for Neglected Diseases initiative (DNDi) hosted a symposium for Visceral Leishmaniasis (VL) experts to discuss the benefits of establishing a global VL data platform and refine a research agenda that will explore key scientific questions to enhance care for VL patients and affecte...

Over 30 organisations have so far signed the Oxford statement developed by IDDO and the Medicines We Can Trust campaign during the first ever-academic conference on Medicine Quality and Public Health in Oxford, 23-28 September.

If you’re in Oxford, UK between now and January 4th, 2019 visit the Radcliffe Science Library at the University of Oxford to see a new art exhibition of 14 prints illustrating the global health impact of poor quality medicines.

Researchers from IDDO and the WorldWide Antimalarial Resistance Network (WWARN) presented at the 9th European and Developing Countries Clinical Trials Partnership (EDCTP) forum held in Lisbon, Portugal from 17-21 September 2018.

Over 200 delegates travelled from more than 50 countries to attend the first ever conference on Medicine Quality and Public Health (MQPH) in Oxford from 23-28 September 2018.

IDDO’s Ebola Data Platform, a pioneering collaboration in Ebola and emerging infections, has opened nominations for members of its Data Access Committee (DAC). Individuals with skills and expertise in clinical research, data protection and management, ethics in research and emergency public health r...

If you’re planning to be at this year’s 67th American Society of Tropical Medicine and Health Annual Meeting in New Orleans, then do come and see us. We’ll be sharing our latest results and tools at Booth 416 – so do stop by to meet the IDDO team to exchange ideas on how we might work together.

The Infectious Diseases Data Observatory (IDDO), together with many partners including the United States Pharmacopeia (USP), the Concept Foundation, the Mahidol Oxford Tropical Medicine Research Unit (MORU) and the Wellcome Trust will host the first Medicine Quality and Public Health conference at K...

We are delighted to attend the 9th EDCTP Forum in Lisbon, Portugal this week.

Bangkok / Oxford, 22 August 2018 – The economic costs of antimicrobial resistance (AMR) for every course of antibiotics are considerable, and much higher than their purchase cost, say researchers.

The 2018 Global Health Journalism Fellowship will invite outstanding young journalists to participate in the first ever international conference on Medicine Quality and Public Health at the University of Oxford. Application deadline is 12 August 2018

A pioneering conference will bring leading professionals from all over the world to Oxford, UK to discuss strategies for tackling poor quality medical products on a global scale.

A new study published today reveals the challenges of establishing sustainable and effective networks to tackle resistance to antimicrobial medicines in low- and middle-income countries (LMICs).

The fourth Quality of Medical Products and Public Health course will take place in Oxford this year, from 17-21 September, at Wolfson College. This multidisciplinary course is aimed at professionals who are interested in the quality of medical products. The application deadline is 18 May.

Two new WHO publications highlight the prevalence and impact of substandard and falsified medical products. An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from the World Health Organization (WHO).

New literature review on soil-transmitted helminths provides compelling evidence for the need to develop a data sharing platform to monitor and improve treatment outcomes for this neglected tropical disease.

The IDDO team will be attending this year’s American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting held in Baltimore, USA. Visit the Centre for Tropical Medicine & Global Health booth (number 312) in the exhibition area to meet staff members.

The IDDO and Be-cause health Medicine Quality teams will be addressing the issue of poor quality medicines at the forthcoming European Congress on Tropical Medicine and International Health (ECTMIH) in Antwerp, Belgium.

The WorldWide Antimalarial Resistance Network (WWARN) has been shortlisted for a 2017 Times Higher Education (THE) Award in the ‘International Collaboration of the Year’ category.

Combining patient data from visceral leishmaniasis (VL) clinical trials would give scientists and clinicians more tools to understand and treat the disease which can be fatal if untreated.